Abstract
The SAPHO (synovitis, acne, pustulosis, hyperostosis, and osteitis) syndrome describes an association between skeletal disorders consisting of bone lesions and arthritis and various dermatologic conditions; the most frequent of these are palmoplantar pustolosis and severe acne. The acronym SAPHO was firstly proposed by Chamot and co-workers [1]. Although typical cases have been described in several countries beginning from 1961, under more than 40 different acronyms and denominations including acne induced arthritis, arthro-osteitis associated with severe acne, and recurrent multifocal osteomyelitis [2–4]. Diagnostic criteria proposed by the French authors include (1) osteoarticular manifestations of palmoplantar pustolosis, severe acne (conglobata or fulminans), or hidradenitis suppurativa; (2) hyperostosis of anterior chest wall, spine, pelvis, or limb, with or without dermatosis; or (3) chronic recurrent multifocal osteomyelitis with or without dermatosis [2, 5].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chamot AM, Benhamou CL, Kahn MF, et al. Le Syndrome Acne Pustolose Hyperostose Ostéite (SAPHO). Resultats d’une enquete nationale. 85 observations. Rev Rhum Mal Osteoartic. 1987;54:187–96.
Benhamou CL, Chamot AM, Kahn MF. Synovitis-acne-pustolosis hyperostosis-osteomyeltis syndrome (SAPHO): a new syndrome among the spondyloarthropathies? Clin Exp Rheumatol. 1988;6:109–12.
Kahn MF. Psoriatic arthritis and synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. Curr Opin Rheumatol. 1993;5:378–84.
Khan MF, Chamot AM. SAPHO syndrome. Rheum Dis Clin North Am. 1992;18:225–46.
Kahn MF, Kahn MA. The SAPHO syndrome. Baillere’s Clin Rheumatol. 1994;8:333–62.
Sonozaki H, Kawashima M, Hongo O, et al. Incidence of arthro-osteitis in patients with pustolosis palmaris and plantaris. Ann Rheum Dis. 1981;40:554–7.
Sonozaki H, Mitsui H, Miyanaga Y, et al. Clinical features of 53 cases with pustolotic arthroosteitis. Ann Rheum Dis. 1981;40:547–53.
Hayem G, Bouchaud-Chabot A, Benaali K, et al. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum. 1999;29:159–71.
Maugars Y, Berthelot JM, Ducloux JM, et al. SAPHO syndrome: a follow-up study of 19 cases with special emphasis on enthesis involvement. J Rheumatol. 1995;22:2135–41.
Reith JD, Bauer TW, Schils JP. Osseus manifestations of SAPHO (synovitis, acne, pustolosis, hyperostosis, osteitis) syndrome. Am J Surg Pathol. 1996;20:1368–77.
Schilling F, Kessler S. The SAPHO syndrome – Clinical and radiological differentiation and classification on the basis of 86 cases. Z Rheumatol. 2000;59:1–28.
Toussirot E, Dupond JL, Wending D. Spondylodiscitis in SAPHO syndrome: a series of eight cases. Ann Rheum Dis. 1997;56:52–8.
Trotta F, La Corte R, Bajocchi G, et al. Hyperostosis and multifocal osteitis: a purely rheumatological subset of SAPHO syndrome. Clin Exp Rheumatol. 1990;8:401–4.
Steinhoff JP, Cilursu A, Falasca GF, et al. A study of musculoskeletal manifestations in 12 patients with SAPHO syndrome. J Clin Rheumatol. 2002;8:13–22.
Van Doorum S, Barraclough D, McColl G, et al. SAPHO: rare or just nor recognized? Semin Arthritis Rheum. 2000;30:70–7.
Amor B, Dougados M, Mijiyama M. Critères de classification des spondyl-arthropathies. Rev Rhum Mal Osteoartic. 1990;57:85–9.
Dougados M, Van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218–27.
Goupille P, Valat JP. SAPHO syndrome and spondyloarthropathy. J Rheumatol. 1996;23:1667–8.
Edlund E, Johnsson U, Lidgren L, et al. Palmoplantar pustolosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis. 1988;47:809–15.
Wagner AD, Mai U, Hammer M, et al. Long term antibiotic therapy successful in patients with SAPHO syndrome [abstract]. Arthritis Rheum. 1997;40 Suppl 9:S62.
Kirchhoff T, Merkesdal T, Rosenthal H, et al. Diagnostic management of patients with SAPHO syndrome: use of MR imaging to guide bone biopsy at CT for microbiological and histological work-up. Eur Radiol. 2003;13:2304–8.
Colina M, Lo Monaco A, Khodeir M, Trotta F. Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol. 2007;25:457–60.
Kahn MF, Bouvier MD, Palazzo E, et al. Sterno-clavicular pustolotic osteitis (SAPHO): 20 year interval between skin and bone lesions. J Rheumatol. 1991;18:1104–8.
Touma Z, Arayssi T. Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome. J Clin Rheumatol. 2007;13:338–40.
Ballara SC, Siraj QH, Maini RN, et al. Sustained response to doxycycline therapy in two patients with SAPHO syndrome. Arthritis Rheum. 1999;42:819–21.
Hagemann D, Pfaffenbach B, Schmid G, Adamek RJ. Wirbelkörpederstruktionen mit massiven schmerzen durch das SAPHO-syndrom. Dtsh Med Wschr. 1999;124: 114–8.
Schilling F, Wagner AD. Azithromycin: eine anti-inflammatorische wirksamkeit im einsatz bei der chronischen rekurrierenden multifokalen osteomyelitis? Eine vorläufige mitteilung. Z Rheumatol. 2000;59:352–3.
Donelly S, Doyle DV. Chronic diffuse sclerosing osteomyelitis of the humerus. Novel treatment with calcitonin. J Rheumatol. 1993;20:1073–6.
Misaki T, Dokos S, Mori E. Calcitonin treatment for intersternoclavicular ossification: clinical experience in two cases. Ann Rheum Dis. 1991;50:813–6.
Amital H, Applabaum H, Aamar S, et al. SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford). 2004;43:658–61.
Kerrison C, Davidson JE, Clearly AG, et al. Pamidronate in the treatment of childhood SAPHO syndrome. Rheumatology (Oxford). 2004;43:1246–51.
Kopterides P, Pikazis D, Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum. 2004;50:2970–3.
Solau-Gervais E, Soubrier E, Gerot I, et al. The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome. Rheumatology (Oxford). 2006;45:339–42.
Pennanen N, Lapinjoki S, Urtti A, et al. Effect of liposomal and free bisphosphonates on the IL-1β, IL-6 and TNF-α secretion from RAW 264 cells in vitro. Pharm Res. 1995;12:916–22.
Braun J, Barakliakos X, Brandt J, et al. Therapy of ankylosing spondylitis. Part II: biological therapies in the spondyloarthritides. Scand J Rheumatol. 2005;34: 178–90.
Olivieri I, Padula A, Ciancio G, et al. Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis. 2002;61:375–6.
Olivieri I, Padula A, Ciancio G, et al. Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome: comment on the artiche by Wagner et al. Arthritis Rheum. 2003;48:1467.
Wagner AD, Andresen J, Jedro MC, et al. Sustained response to tumor necrosis factor α-blocking agents in two patients with SAPHO syndrome. Arthritis Rheum. 2002;46:1965–8.
Iqbal M, Kolodney MS. Acne fulminans with synovitis-acne-pustolosis-hyperostosis-osteitis (SAPHO) syndrome treated with infliximab. J Am Acad Dermatol. 2005;52(5 suppl 1):S118–20.
Massara A, Cavazzini PL, Trotta F. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Rheumatology (Oxford). 2006;45:730–3.
Deutshmann A, Mache CJ, Bodo K, et al. Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-alpha blockage. Pediatrics. 2005;116:1231–3.
Carpenter E, Jackson MA, Friesen CA, et al. Crohn’s-associated chronic recurrent multifocal osteomyelitis responsive to infliximab. J Pediatr. 2004;144:541–4.
Moll C, Hernández MV, Cañete JD, et al. Ilium osteitis as the main manifestation of the SAPHO syndrome: response to infliximab therapy and review of the literature. Semin Arthritis Rheum. 2008;37(5): 299–306.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Olivieri, I., Giasi, V., D’Angelo, S., Palazzi, C., Padula, A. (2014). The SAPHO Syndrome. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_77
Download citation
DOI: https://doi.org/10.1007/978-3-540-69375-8_77
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69374-1
Online ISBN: 978-3-540-69375-8
eBook Packages: MedicineMedicine (R0)